- Latest week
- 17 Jul 2026
- Close
- 7.850000
- Fair value
- 6.323987
- Next-week expectancy
- Undecided 53.69%
GNOM Chart Pack
Global X Genomics & Biotechnology UCITS ETF
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, GNOM rose 24.92%, moving from 6.28 to 7.85. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 6 of the last 12 weeks. Relative Strength is 12.53 and has improved across the 12-week window. Market Dynamics is 1.50 on the latest week. Next-week expectancy is undecided at 53.69% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 7.85
- 12-Week Change
- 24.92%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.69%
- Signal Weeks
- 6 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 12.53
- Market Dynamics
- 1.50
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 7.85
- 12-Week Change
- 24.92%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.69%
- Signal Weeks
- 6 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 12.53
- Market Dynamics
- 1.50
Over the latest 12 completed weeks ending 2026-07-17, GNOM rose 24.92%, moving from 6.28 to 7.85. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 6 of the last 12 weeks. Relative Strength is 12.53 and has improved across the 12-week window. Market Dynamics is 1.50 on the latest week. Next-week expectancy is undecided at 53.69% based on similar historical setup states.